Trisha M Parekh1, Smita Bhatia2, Andrea Cherrington3, Young-Il Kim4, Allison Lambert5, Anand Iyer4, Elizabeth A Regan6, Dawn L DeMeo7, MeiLan Han8, Mark T Dransfield9. 1. Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA. Electronic address: trishaparekh@uabmc.edu. 2. Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, USA. 3. Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, USA. 4. Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA. 5. Division of Pulmonary, Critical Care, And Sleep Medicine, University of Washington, Spokane, WA, USA. 6. Department of Medicine, National Jewish Health, Denver, CO, USA. 7. Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 8. Division of Pulmonary, Allergy, and Critical Care, University of Michigan, Ann Arbor, MI, USA. 9. Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Alabama at Birmingham, USA; Birmingham VA Medical Center, Birmingham, AL, USA.
Abstract
INTRODUCTION: Current and former smokers with normal spirometry and with Preserved Ratio Impaired Spirometry (PRISm) experience respiratory events similar to chronic obstructive pulmonary disease (COPD) exacerbations. Exacerbations significantly reduce quality of life (QoL) in COPD patients however the effect of respiratory exacerbations on QoL in these groups is unknown. We hypothesized that exacerbations and change in exacerbation status would predict QoL decline among normal spirometry and PRISm participants in COPDGene. METHODS: COPDGene is a multicenter, longitudinal study in the U.S. designed to identify genetic determinants of COPD. We enrolled study subjects in Phase 1 of COPDGene and performed multivariable logistic regression models to determine independent predictors of decline in quality of life [>4 points on the St George's Respiratory Questionnaire (SGRQ)]. Separate analyses were performed for current and former smokers with normal spirometry and PRISm. Frequent exacerbator status was defined by > 2 moderate or >1 severe exacerbations in the year prior to the baseline and year 5 follow-up visits. RESULTS: Independent predictors of QoL deterioration included current smoking, higher exacerbation frequency, and a change from infrequent to frequent exacerbation status (REF: infrequent to infrequent exacerbation status) in both groups [PRISm (OR = 3.15,95%CI, 1.67-5.94), normal spirometry (OR = 4.72,95%CI, 3.25-6.86)]. A change from frequent to infrequent exacerbation status did not lower the odds of QoL decline in either cohort. CONCLUSION: Continued smoking and the onset of frequent exacerbations were predictors of QoL decline in smokers with normal spirometry and PRISm. Further studies are needed to identify modifiable factors associated with decline in QoL in smokers.
INTRODUCTION: Current and former smokers with normal spirometry and with Preserved Ratio Impaired Spirometry (PRISm) experience respiratory events similar to chronic obstructive pulmonary disease (COPD) exacerbations. Exacerbations significantly reduce quality of life (QoL) in COPDpatients however the effect of respiratory exacerbations on QoL in these groups is unknown. We hypothesized that exacerbations and change in exacerbation status would predict QoL decline among normal spirometry and PRISm participants in COPDGene. METHODS:COPDGene is a multicenter, longitudinal study in the U.S. designed to identify genetic determinants of COPD. We enrolled study subjects in Phase 1 of COPDGene and performed multivariable logistic regression models to determine independent predictors of decline in quality of life [>4 points on the St George's Respiratory Questionnaire (SGRQ)]. Separate analyses were performed for current and former smokers with normal spirometry and PRISm. Frequent exacerbator status was defined by > 2 moderate or >1 severe exacerbations in the year prior to the baseline and year 5 follow-up visits. RESULTS: Independent predictors of QoL deterioration included current smoking, higher exacerbation frequency, and a change from infrequent to frequent exacerbation status (REF: infrequent to infrequent exacerbation status) in both groups [PRISm (OR = 3.15,95%CI, 1.67-5.94), normal spirometry (OR = 4.72,95%CI, 3.25-6.86)]. A change from frequent to infrequent exacerbation status did not lower the odds of QoL decline in either cohort. CONCLUSION: Continued smoking and the onset of frequent exacerbations were predictors of QoL decline in smokers with normal spirometry and PRISm. Further studies are needed to identify modifiable factors associated with decline in QoL in smokers.
Authors: J Taylor Hays; Ivana T Croghan; Christine L Baker; Joseph C Cappelleri; Andrew G Bushmakin Journal: Eur J Public Health Date: 2010-09-30 Impact factor: 3.367
Authors: M Miravitlles; M Ferrer; A Pont; R Zalacain; J L Alvarez-Sala; F Masa; H Verea; C Murio; F Ros; R Vidal Journal: Thorax Date: 2004-05 Impact factor: 9.139
Authors: Nirupama Putcha; Milo A Puhan; M Bradley Drummond; MeiLan K Han; Elizabeth A Regan; Nicola A Hanania; Carlos H Martinez; Marilyn Foreman; Surya P Bhatt; Barry Make; Joe Ramsdell; Dawn L DeMeo; R Graham Barr; Stephen I Rennard; Fernando Martinez; Edwin K Silverman; James Crapo; Robert A Wise; Nadia N Hansel Journal: PLoS One Date: 2014-12-16 Impact factor: 3.240
Authors: W C Tan; J Bourbeau; P Hernandez; K R Chapman; R Cowie; J M FitzGerald; D D Marciniuk; F Maltais; A S Buist; D E O'Donnell; D D Sin; S D Aaron Journal: Thorax Date: 2014-04-04 Impact factor: 9.139